Profile: Berkeley Advanced Biomaterials, Inc. manufactures skeletal repair resorbable biomaterials. We offer a large variety of products with tailored morphologies and microstructures to match the needs of orthopedic surgery, bone tissue engineering, and life science research. Our ostetic product line, cem-ostetic® and bi-ostetic™ bone void fillers, are based on hydroxyapatite (HAP) and tricalcium phosphate (TCP) technologies. These products are available in granule, block and injectable putty formulations. Our ostetic products such as bi-ostetic™ and cem-ostetic®) are based on hydroxyapatite (HAP) technology. Our bi-ostetic™ is a synthetic bone filler tailored for slow resorbtion & is based on tricalcium phosphate (TCP) and hydroxyapatite (HAP). Our cem-ostetic® is a neutral pH bone putty that contains calcium-based biocompatible calcium salts & is used in orthopedic surgery.

The company was founded in 1996, has revenues of USD 1-5 Million and is ISO 9001, CE certified.

FDA Registration Number: 3003586